89
Views
0
CrossRef citations to date
0
Altmetric
Hepatology

Clinical Application of Serum Interleukin-6 Combined with Inflammatory Cytokines in the Dynamic Monitoring of Patients with Acute Cholecystitis

, , &
Pages 503-508 | Received 18 Oct 2023, Accepted 14 Jan 2024, Published online: 08 Feb 2024

References

  • Gallaher JR, Charles A. Acute cholecystitis: a review. JAMA. 2022;327(10):965–975. doi:10.1001/jama.2022.2350
  • Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:41–54. doi:10.1002/jhbp.515
  • Lee SO, Yim SK. [management of acute Cholecystitis]. Korean J Gastroenterol. 2018;71:264–268. Korean. doi:10.4166/kjg.2018.71.5.264
  • Sato N, Kinoshita A, Imai N, et al. Inflammation-based prognostic scores predict disease severity in patients with acute cholecystitis. Eur J Gastroenterol Hepatol. 2018;30:484–489. doi:10.1097/MEG.0000000000001063
  • Sethwala AM, Goh I, Amerena JV. Combating inflammation in cardiovascular disease. Heart Lung Circ. 2021;30:197–206. doi:10.1016/j.hlc.2020.09.003
  • Steffens S, Mach F. Inflammation and atherosclerosis. HERZ. 2004;29:741–748. doi:10.1007/s00059-004-2634-9
  • Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24:287. doi:10.1186/s13054-020-02993-5
  • Mierzchala-Pasierb M, Lipinska-Gediga M. Sepsis diagnosis and monitoring - procalcitonin as standard, but what next? Anaesthesiol Intensive Ther. 2019;51:299–305. doi:10.5114/ait.2019.88104
  • Yaow C, Chong R, Chan KS, Chia C, Shelat VG. Should procalcitonin be included in acute cholecystitis guidelines? A systematic review. Medicina (Kaunas). 2023;60:59. doi:10.3390/medicina60010059
  • Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a16295. doi:10.1101/cshperspect.a016295
  • Dawson RE, Jenkins BJ, Saad MI. IL-6 family cytokines in respiratory health and disease. Cytokine. 2021;143:155520. doi:10.1016/j.cyto.2021.155520
  • Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50:1007–1023. doi:10.1016/j.immuni.2019.03.026
  • Johnson C, Han Y, Hughart N, McCarra J, Alpini G, Meng F. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer. 2012;1:58–70. doi:10.3978/j.issn.2224-4778.2011.11.02
  • Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49(1):S57–S61.
  • Matwiyoff GN, Prahl JD, Miller RJ, et al. Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res. 2012;61:401–409. doi:10.1007/s00011-012-0439-5
  • Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiol Rev. 2019;99:1223–1248. doi:10.1152/physrev.00012.2018